FDA approves deflazacort for muscular dystrophy patients
The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »
Competition Act tabled by House committee
The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »
CDC works in partnership to help Native Americans control diabetes
The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes. Read More »
VA to expand pharmacists' roles in health care management
The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities. Read More »
Legislation allows Medicare to pay pharmacists for additional services
Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »
Evidence building of PBMs' ability to control Rx costs
Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »
Hennessey joins NQF's Medicaid Innovation Accelerator Project
Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »
CMS nominee Verma backs PBMs in Medicare Part D
"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »
Critics worry Trump will undo FDA safeguards
Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »
CMS offers resources to expand pharmacy care
The Center for Medicaid and CHIP Services is encouraging pharmacies to extend the scope of dispensing medications to foster immediate access to certain drugs. Read More »
Speakers for upcoming PDA conference announced
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
Taxpayer groups oppose changes to 'process by which drug prices are negotiated for Medicare Part D'
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
FDA issues new naming guidance for biologics, biosimilars
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
NIAID releases new guidelines for peanut allergy prevention
The National Institute of Allergy and Infectious Diseases recently released new guidelines to help health care providers and family members manage and prevent peanut allergies in infants. Read More »
Proposed CMS antimicrobial program hits delay with presidential transition
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Study seeks data on generic medication preferences
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
AHSP applauds 21st Century Cures Act
The American Journal of Health-System Pharmacy has applauded the 21st Century Cures Act was signed into law by President Barack Obama on Dec. 13. Read More »
Direct Relief airlifts 82 tons of medical aid to Haiti
Direct Relief recently announced that it airlifted 82 tons of medical aid to Haiti for the treatment of cholera and other diseases that have become rampant since Hurricane Matthew in October. Read More »
FDA approves Intrarosa for moderate to severe pain during intercourse
Intrarosa (prasterone), which is designed for women who experience moderate to severe pain during sex, has been approved by the U.S. Food and Drug Administration. Read More »
Akebia, Otsuka collaborate on drug to treat chronic kidney disease-induced anemia
Akebia Therapeutics Inc. and Otsuka Pharmaceutical Co. Ltd. recently entered a collaboration and license agreement in the U.S. for vadadustat, an oral hypoxia-inducible factor stabilizer in development for the treatment of anemia associated with chronic kidney disease Read More »
Alerts Sign-up